Nuveen Asset Management, LLC Intra Cellular Therapies, Inc. Transaction History
Nuveen Asset Management, LLC
- $345 Billion
- Q3 2024
A detailed history of Nuveen Asset Management, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 487,922 shares of ITCI stock, worth $42.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
487,922
Previous 567,824
14.07%
Holding current value
$42.2 Million
Previous $38.9 Million
8.26%
% of portfolio
0.01%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding ITCI
# of Institutions
378Shares Held
84.7MCall Options Held
319KPut Options Held
143K-
Vanguard Group Inc Valley Forge, PA9.63MShares$834 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$547 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.29MShares$458 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$333 Million1.4% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.05MShares$264 Million3.36% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $8.17B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...